Pathophysiology of Thrombosis and Virchow's Triad

The primary objectives of these lectures are to describe the pathophysiology of thrombosis and the pharmacology of three major drug classes: - Antiplatelets: Specifically target and interfere with primary hemostasis. - Anticoagulants: Target and interfere with secondary hemostasis (the coagulation cascade). - Fibrinolytics (Fibrinogenetics): Specifically designed to break down existing fibrin within a clot.

Immediate Response to Vascular Damage: The initial reaction to blood vessel wall damage is vasoconstriction. This physiological response reduces blood flow to the affected area, minimizing potential blood loss.
Primary Hemostasis: - Exposure of collagen and von Willebrand factor occurs at the site of injury. - Platelets adhere to these exposed elements, leading to platelet activation and subsequent aggregation. - This process culminates in the formation of a temporary platelet plug.
Secondary Hemostasis: - Triggered by the exposure of collagen and, more critically in vivo, the exposure of tissue factor. - This activates the coagulation cascade, ultimately leading to the formation of thrombin. - Thrombin acts as an enzyme that converts soluble fibrinogen into insoluble, stable fibrin. - Fibrin forms a meshwork that stabilizes the clot.
Dual Role of Thrombin: Beyond converting fibrinogen, thrombin and other components of the coagulation cascade also act to promote further platelet activity.
Fibrinolysis and Repair: As growth and repair of the vessel wall occur, the fibrin is dissolved by the enzyme plasmin to restore the blood vessel wall to its normal state.

Thrombosis: Defined as the pathological formation of a hemostatic plug within the vasculature in the absence of active bleeding. It occurs when a plug forms despite there being no wound to seal.
Technical Differences: - Blood Clot: Technically refers to a formation occurring in vitro (outside the body, such as in a glass tube). Clots are characterized by a diffuse fibrin meshwork where red and white blood cells are trapped indiscriminately. They are described as amorphous, lacking a distinct internal structure. - Thrombus (Plural: Thrombi): Refers to a formation occurring in vivo (within the body). Thrombi possess clear, distinct structures. Notably, arterial thrombi and venous thrombi have different structural compositions.

Thrombosis is driven by three primary contributing factors collectively known as Virchow’s Triad: - Endothelial Injury - Abnormal Blood Flow - Hypercoagulability

Shear Stress: This is essentially a frictional force exerted as blood moves along the vascular wall. It is particularly significant in arteries due to high-pressure blood flow.
Causes of Injury: - Hypertension: Increases high-pressure shear stress on vessel walls. - Hyperlipidemia and Atherosclerosis: Linked to progressional damage and shear stress. - Metabolic Factors: Increased blood glucose levels can directly damage blood vessels. - Physical Trauma: Including surgical procedures or external wounds. - Infection: Certain infections can lead to direct endothelial damage.
Consequences of Injury: - Exposure of sub-endothelial collagen and tissue factor, which potentialize thrombus formation. - Loss of healthy endothelium leads to a decrease in the production of natural anticoagulants usually secreted by an intact vessel wall.

Laminar Flow: In a healthy artery, blood flow is "laminar," meaning it flows in even, orderly shapes throughout the vessel.
Turbulent Flow: - Primarily an issue in arteries, often caused by obstructions like atherosclerotic plaques. - As blood forces its way through narrowed passages, flow becomes chaotic rather than laminar. - This causes platelets to come into direct contact with the endothelium (striking the sides) and can cause physical damage to the vessel wall.
Stasis: - Defined as immobile or stationary blood. - In Arteries: Turbulence can create small "pockets of stasis" behind obstructions. - In Veins: Stasis is a major issue in veins because blood does not move under high pressure, making pooling more likely. - Pathophysiological Effect: Stasis prevents the dilution of activated coagulation factors. In normal flow, factors are swept away and diluted; in stasis, these factors become concentrated in one area, significantly increasing the likelihood of fibrin formation.

This refers to an increased systemic or local ability of the blood to coagulate.
Genetic Factors: Certain inherited disorders can predispose individuals to hypercoagulability.
Factor V Leiden Mutation: - A specific genetic mutation where the individual produces a variant of Factor V. - This mutated form of Factor V is resistant to cleavage (inactivation) by Protein C. - Since Protein C is a natural anticoagulant meant to deactivate Factor V, the mutation prevents this regulatory step, leading to a pro-thrombotic state.